Assignee
PALLEON PHARMACEUTICALS INC
US·1 granted patent·15 pending applications·1 citations·filing 2017–2024
Top patents by PatentIndex Score
16 records- 0169US11965188B2Recombinant human sialidases, sialidase fusion proteins, and methods of using the samePALLEON PHARMACEUTICALS INC·Filed 2019·Granted Apr 23, 2024·1 cites·43 claims
- 0262US2024344046A1Recombinant human sialidases, sialidase fusion proteins, and methods of using the samePALLEON PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0353US2021253695A1Use of siglec-7 or siglec-9 antibodies for the treatment of cancerPALLEON PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0448US2024067729A1Anti-pd-l1 antibodies and fusion proteins thereofPALLEON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0548US2024059773A1Sialidase-pd-1-antibody fusion proteins and methods of use thereofPALLEON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0648US2024156979A1Anti-inflammatory siglec proteins and methods of making and using samePALLEON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0746US2024059792A1Sialidase-her2-antibody fusion proteins and methods of use thereofPALLEON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0846US2023265406A1Recombinant sialidases with reduced protease sensitivity, sialidase fusion proteins, and methods of using the samePALLEON PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0945US2025049846A1Methods and compositions for treating cancer with immune cellsPALLEON PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1042US2022372458A1Sialidase-pd-l1-antibody fusion proteins and methods of use thereofPALLEON PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1142US2019023786A1Use of siglec-7 or siglec-9 antibodies for the treatment of cancerPALLEON PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1242US2022362351A1Recombinant sialidases and methods of using the samePALLEON PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1341US2022387616A1Sialidase-her2-antibody fusion proteins and methods of use thereofPALLEON PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1441US2022380742A1Sialidase-cd20-antibody fusion proteins and methods of use thereofPALLEON PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1540US2022356457A1Recombinant human sialidases, sialidase fusion proteins, and methods of using the samePALLEON PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1639US2021395333A1Multimeric proteins for detecting a carbohydrate and/or treating a siglec-mediated disorderPALLEON PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PALLEON PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →